The House Oversight and Accountability Committee chaired by Rep. James Comer (R-KY) has summoned FDA Commissioner Robert Califf for a Congressional hearing on April 11. Among other issues like drug shortages and tobacco, the hearing will probe the FDA’s role in hemp markets.
Comer was critical of the FDA’s decision in 2022 to defer to Congress rather than act on CBD regulation. Besides being vocal about hemp issues, it does not appear the chairman has been able to affect change at the agency. From a committee
…
12.20.2024
45z guidance fails to appear; government scrambles to pass spending bill
The US government spending bill failed twice in as many days. If a deal is not reached by midnight on Friday December 20, some federal services will...
12.20.2024
US animal fats and oils end week softer across the board ahead of holiday slowdown
Prices for US animal fats and oils ended the week on a lower note on Friday December 20, with most markets trending downward ahead of the upcoming holiday week,...
12.20.2024
December cattle on feed down on month, year
Most US animal protein prices were rangebound for the week, though in wider ranges due to the impending Christmas and New Year's holiday closures.
The only significant price...